Showing results (161-170 of 223) with videos related to
Sort By:
Pageof 23
Fitoterapia|April 24, 2021
Discovery of naturally occurring inhibitors against SARS-CoV-2 3CL<sup>pro</sup> from Ginkgo biloba leaves via large-scale screeningYuan Xiong, Guang-Hao Zhu, Hao-Nan Wang, et al.Biomaterials|May 28, 2013
Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancerFan Bai, Chao Wang, Qin Lu, et al.Small (Weinheim an Der Bergstrasse, Germany)|January 24, 2023
Targeted Protein Degradation Technology and Nanomedicine: Powerful Allies against CancerJia-Yi Lin, Hai-Jun Liu, Ye Wu, et al.Acta Pharmacologica Sinica|January 25, 2008
Stereoselectivity of satropane, a novel tropane analog, on iris muscarinic receptor activation and intraocular hypotensionLiang Zhu, Li-min Yang, Yong-yao Cui, et al.Pharmacological Research|December 16, 2014
Carbocysteine restores steroid sensitivity by targeting histone deacetylase 2 in a thiol/GSH-dependent mannerYun Song, Hao-Zhong Lu, Jian-Rong Xu, et al.Acupuncture in Medicine : Journal of the British Medical Acupuncture Society|December 1, 2025
Electroacupuncture modulates myocardial insulin signaling and inflammatory markers in a rat model of type 2 diabetesXiao-Xiao Liu, Hai-Hua Zhang, Jian Sun, et al.Biomaterials|December 28, 2014
Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapyYa-Rong Liu, Ying-Yun Guan, Xin Luan, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 30, 2011
Determination of Bis(9)-(-)-Meptazinol, a bis-ligand for Alzheimer's disease, in rat plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetics studyXin-xing Ge, Xiao-lin Wang, Pan Jiang, et al.Nature Communications|June 20, 2014
Relative motions between left flipper and dorsal fin domains favour P2X4 receptor activationWen-Shan Zhao, Jin Wang, Xiao-Juan Ma, et al.Acta Pharmacologica Sinica|May 15, 2020
HKB99, an allosteric inhibitor of phosphoglycerate mutase 1, suppresses invasive pseudopodia formation and upregulates plasminogen activator inhibitor-2 in erlotinib-resistant non-small cell lung cancer cellsQian Liang, Wei-Ming Gu, Ke Huang, et al.Pageof 23